SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hemanta Mukherjee, Durbadal Ojha, Paromita Bag, Himanshu Singh Chandel, Souvik Bhattacharyya, Tapan K. Chatterjee, Pulok K. Mukherjee, Sekhar Chakraborti, Debprasad Chattopadhyay, Anti-herpes virus activities of Achyranthes aspera: An Indian ethnomedicine, and its triterpene acid, Microbiological Research, 2013, 168, 4, 238

    CrossRef

  2. 2
    R. Navarro, E. Vilarrasa, P. Herranz, L. Puig, X. Bordas, J.M. Carrascosa, R. Taberner, M. Ferrán, M. García-Bustinduy, A. Romero-Maté, R. Pedragosa, A. García-Diez, E. Daudén, Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting, British Journal of Dermatology, 2013, 168, 3
  3. 3
    Juan Lv, Qinglong Jin, Haibo Sun, Xiumei Chi, Xiaoli Hu, Hongqing Yan, Yu Pan, Weihua Xiao, Zhigang Tian, Jinlin Hou, Damo Xu, Zhengkun Tu, Junqi Niu, Antiviral Treatment Alters the Frequency of Activating and Inhibitory Receptor-Expressing Natural Killer Cells in Chronic Hepatitis B Virus Infected Patients, Mediators of Inflammation, 2012, 2012, 1

    CrossRef

  4. 4
    Dengming He, Guohua Yan, Yuming Wang, Serum levels of interleukin-12 in various clinical states with hepatitis B virus infection, Cellular Immunology, 2012, 272, 2, 162

    CrossRef

  5. 5
    Nirupma TrehanPati, Shyam Kotillil, Syed S. Hissar, Shikha Shrivastava, Arshi Khanam, Sukriti Sukriti, Siddartha K. Mishra, Shiv Kumar Sarin, Circulating Tregs Correlate with Viral Load Reduction in Chronic HBV-Treated Patients with Tenofovir Disoproxil Fumarate, Journal of Clinical Immunology, 2011, 31, 3, 509

    CrossRef

  6. 6
    Anil Seetharam, Mauricio Lisker-Melman, Treatment of chronic hepatitis B: Are we ready for combination therapy?, Current Gastroenterology Reports, 2009, 11, 1, 22

    CrossRef

  7. 7
    M. KUMAR, S. K. SARIN, Systematic review: combination therapies for treatment-naïve chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2008, 27, 12
  8. 8
    Eirini I. Rigopoulou, Deepak Suri, Shilpa Chokshi, Ivana Mullerova, Steven Rice, Richard S. Tedder, Roger Williams, Nikolai V. Naoumov, Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity, Hepatology, 2005, 42, 5
  9. 9
    Youngil I. Koh, Inseon S. Choi, Chang-Hwan Park, Jae-Sook Ahn, Seung-Gyu Ji, The Inverse Association Between the Presence of Antibody to Hepatitis B Surface Antigen and Atopy in Young Adults, The Korean Journal of Internal Medicine, 2005, 20, 3, 210

    CrossRef

  10. 10
    Sergey V. Sennikov, Sergey V. Krysov, Tatiana V. Injelevskaya, Alexandr N. Silkov, Lyubov V. Grishina, Vladimir A. Kozlov, Quantitative analysis of human immunoregulatory cytokines by electrochemiluminescence method, Journal of Immunological Methods, 2003, 275, 1-2, 81

    CrossRef

  11. 11
    C. N. Kocabas, Do hepatitis B virus carriers develop atopic diseases?, Allergy, 2001, 56, 11
  12. 12
    G. Piazzolla, C. Tortorella, G. Fiore, M. Fanelli, A. Pisconti, S. Antonaci, Interleukin-12 p40/p70 Ratio andIn VivoResponsiveness to IFN-αTreatment in Chronic Hepatitis C, Journal of Interferon & Cytokine Research, 2001, 21, 7, 453

    CrossRef

  13. 13
    Pierre Vandepapelière, Sexually Transmitted Diseases, 2000,

    CrossRef